Obesity and associated metabolic diseases, including type 2 diabetes, cardiovascular diseases, and certain cancers, poses ...
Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently receiving approvals by the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results